Early detection of atrial fibrillation in patients with heart failure reduces the risk of subsequent hospitalization: a subanalysis of the randomized TIM-HF2 trial.
Tina StegmannKerstin KoehlerMarie SchulzeUlrich LaufsFriedrich KoehlerRolf WachterPublished in: European heart journal. Digital health (2022)
In this subgroup of HF patients in the TIM-HF2 trial, non-invasive daily ECG transmission leads to a four times higher detection rate of new AF compared with UC. This was associated with a significant reduction of days lost due to unplanned cardiovascular hospitalizations, especially hospitalizations related to AF.
Keyphrases
- phase iii
- atrial fibrillation
- phase ii
- open label
- clinical trial
- end stage renal disease
- study protocol
- double blind
- newly diagnosed
- chronic kidney disease
- acute heart failure
- heart failure
- ejection fraction
- prognostic factors
- placebo controlled
- left atrial
- oral anticoagulants
- catheter ablation
- randomized controlled trial
- heart rate variability
- left atrial appendage
- heart rate
- venous thromboembolism
- patient reported outcomes
- blood pressure
- left ventricular
- acute coronary syndrome
- label free